Merck CDR (CAD Hedged) (MRK : TSX)
Common Stock
$28.53
CAD
+0.91 (3.29%)
Last updated: 2026-07-16
MRK
Merck CDR (CAD Hedged)
WealthAwesomePerformance
1 Day
+3.29%
1 Week
+1.78%
1 Month
+10.88%
YTD
+18.78%
Key Statistics
Market Cap
$296.29B
52W High
$30.21
52W Low
$16.98
P/E Ratio
35.11
50 Day MA
$26.82
200 Day MA
$26.37
Beta
-
Dividend Yield
11.50%
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/16/2026 | $28.14 | $28.78 | $28.14 | $28.53 | $28.53 | 8,892 |
| 7/15/2026 | $27.66 | $27.66 | $27.59 | $27.62 | $27.62 | 7,838 |
| 7/14/2026 | $27.70 | $27.70 | $26.92 | $26.95 | $26.95 | 7,266 |
| 7/13/2026 | $27.56 | $27.75 | $27.47 | $27.72 | $27.72 | 2,842 |
| 7/10/2026 | $27.72 | $27.72 | $27.63 | $27.63 | $27.63 | 721 |
| 7/9/2026 | $28.25 | $28.25 | $28.03 | $28.03 | $28.03 | 523 |
| 7/8/2026 | $28.29 | $28.29 | $28.29 | $28.29 | $28.29 | 127 |
| 7/7/2026 | $28.34 | $28.34 | $28.34 | $28.34 | $28.34 | 0 |
| 7/6/2026 | $29.24 | $29.24 | $28.18 | $28.32 | $28.32 | 1,160 |
| 7/3/2026 | $29.25 | $30.21 | $29.25 | $29.83 | $29.83 | 1,202 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MRK's historical volatility
30-Day Vol
34.0%
Annualized
90-Day Vol
30.0%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$34.11
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$30.28 | C$26.93 – C$34.05 |
| 60 trading days | C$32.14 | C$27.22 – C$37.94 |
| 90 trading days | C$34.11 | C$27.83 – C$41.80 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Merck CDR (CAD Hedged)
Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and anti-PD-1 therapy, as well as KEYTRUDA (pembrolizumab) in patients with advanced solid tumors. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Financials
- Revenue (TTM)
- $0
- EBITDA
- -
- Profit Margin
- 0.00%
- ROE (TTM)
- 3690.70%
- EPS (Diluted)
- 0.00
- Book Value
- -
💰 Recent Dividends
$0.1915
Ex: Dec 15, 2025
$0.1848
Ex: Sep 15, 2025
$0.1851
Ex: Jun 16, 2025
$0.1837
Ex: Mar 17, 2025
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE Report